Literature DB >> 14750574

Regression of orbital myocysticercosis: an ultrasonographic study.

P Puri1, A K Grover.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14750574     DOI: 10.1023/b:inte.0000006872.64285.f4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


× No keyword cloud information.
  7 in total

1.  Medical management of orbital myocysticercosis: a pilot study.

Authors:  P Puri; A K Grover
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

2.  MR imaging in cysticercotic encephalitis.

Authors:  O H Del Brutto; M A Zenteno; P Salgado; J Sotelo
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

3.  Oral albendazole in the management of extraocular cysticercosis.

Authors:  R Sihota; S G Honavar
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

4.  Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.

Authors:  J Sotelo; F Escobedo; P Penagos
Journal:  Arch Neurol       Date:  1988-05

5.  Orbital cysticercosis.

Authors:  G C Sekhar; B N Lemke
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

6.  Albendazole therapy in orbital cysticercosis.

Authors:  V K Srivastava; A Srivastava; K C Singhal
Journal:  Indian J Physiol Pharmacol       Date:  1996-07

7.  ELISA in the diagnosis of neurocysticercosis.

Authors:  N Rosas; J Sotelo; D Nieto
Journal:  Arch Neurol       Date:  1986-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.